Skip to content
Open access · CC-BY via OpenAlex

Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?

Ashly Hindle, Sharda Prakash Singh, Jangampalli Adi Pradeepkiran, Chhanda Bose, Murali Vijayan, Sudhir Kshirsagar, Neha A. Sawant, P. Hemachandra Reddy

International Journal of Molecular Sciences · 2022 · ▲ 14 citations

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and is the most common cause of dementia in older people. AD is associated with the loss of synapses, oxidative stress, mitochondrial structural and functional abnormalities, microRNA deregulation, inflammatory responses, neuronal loss, accumulation of amyloid-beta (Aβ) and phosphorylated tau (p-tau). AD occurs in two forms: early onset, familial AD and late-onset, sporadic AD. Causal factors are still unknown for a vast majority of AD patients. Genetic polymorphisms are proposed to contribute to late-onset AD via age-dependent increases in oxidative stress and mitochondrial abnormalities. Recent research from our lab revealed that reduced levels of Rlip76 induce oxidative stress, mitochondrial dysfunction(definition) and synaptic damage, leading to molecular and behavioral phenotypes resembling late-onset AD. Rlip76 is a multifunctional 76 kDa protein encoded by the RALBP1 gene, located on chromosome 18. Rlip is a stress-protective ATPase of the mercapturic acid pathway that couples clathrin-dependent endocytosis with the efflux of glutathione–electrophile conjugates. Rlip is evolutionarily highly conserved across species and is ubiquitously expressed in all tissues, including AD-affected brain regions, the cerebral cortex and hippocampus, where highly active neuronal metabolisms render the cells highly susceptible to intracellular oxidative damage. In the current article, we summarize molecular and cellular features of Rlip and how depleted Rlip may exacerbate oxidative stress, mitochondrial dysfunction and synaptic damage in AD. We also discuss the possible role of Rlip in aspects of learning and memory via axonal growth, dendritic remodeling, and receptor regulation. We conclude with a discussion of the potential for the contribution of genetic polymorphisms in Rlip to AD progression and the potential for Rlip-based therapies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms23116098
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Hindle, A., Singh, S.P., Pradeepkiran, J.A., Bose, C., Vijayan, M., Kshirsagar, S., Sawant, N.A., &amp; Reddy, P.H. (2022). Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms23116098
Vancouver
Hindle A, Singh SP, Pradeepkiran JA, Bose C, Vijayan M, Kshirsagar S, et al. Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms23116098.
BibTeX
@article{ashly2022RlipAn, title = {Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?}, author = {Ashly Hindle and Sharda Prakash Singh and Jangampalli Adi Pradeepkiran and Chhanda Bose and Murali Vijayan and Sudhir Kshirsagar and Neha A. Sawant and P. Hemachandra Reddy}, journal = {International Journal of Molecular Sciences}, year = {2022}, doi = {10.3390/ijms23116098}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings